VistaGen Therapeutics(VTGN) - 2022 Q2 - Earnings Call Transcript

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q2 2022 Earnings Conference Call November 10, 2021 5:00 PM ET Company Participants Mark Flather – Vice President of Investor Relations Shawn Singh – Chief Executive Officer Jerry Dotson – Chief Financial Officer Mark Smith – Chief Medical Officer Conference Call Participants Brian Skorney – Robert W. Baird Tim Lugo – William Blair Jason McCarthy – Maxim Group Andrew Tsai – Jefferies Operator Greetings, and welcome to VistaGen Therapeutic Second Quarter of Fiscal Yea ...